logo

Windtree Therapeutics has signed a $520 million new financing agreement, which will be used to purchase BNB.

By: theblockbeats.news|2025/07/25 03:22:18

BlockBeats News, July 25th, Nasdaq-listed biotechnology company Windtree Therapeutics (WINT) announced that it has entered into a share purchase agreement of up to $500 million to establish an Equity Line of Credit (ELOC). Additionally, the company has also signed an additional $20 million stock purchase agreement with Build and Build Corp.

The total funding size of this round reaches up to $520 million, with 99% of the funds to be used to purchase BNB. The company plans to officially start using the funds after obtaining shareholder approval to increase the number of authorized common shares.

Ripple e SEC chegam em um acordo, encerrando o processo judicial
WEEX rouba a cena no BlockchainRIO 2025

Você também pode gostar

Compartilhar
copy

Ganhadores

Últimas notícias sobre cripto

02:58

A co-fundadora Lopes Lara se torna a bilionária mais jovem do mundo.

02:56

Cryptocurrency Fear and Greed Índice Rebounds to 28, Exiting "Extreme Fear" Range

02:53

Os rendimentos da JGB aumentam como o mercado se concentra nos dados econômicos desta semana

02:51

NewGen: Em 28 de novembro, já comprou 13,000.23 SOL

02:27

Prominent Analyst: Pode Ethereum quebrar $3,700 para validar se o mercado de touros terminou

Leia mais
Comunidade
icon
icon
icon
icon
icon
icon
icon
icon

Atendimento ao cliente@weikecs

Parcerias comerciais@weikecs

Quant trading e MM[email protected]

Serviços VIP[email protected]